Nasal vaccine trials to combat stomach-flu bug
Steve Connor is the Science Editor of The Independent. He has won many awards for his journalism, including five-times winner of the prestigious British science writers’ award; the David Perlman Award of the American Geophysical Union; twice commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and a special merit award of the European School of Oncology for his investigative journalism. He has a degree in zoology from the University of Oxford and has a special interest in genetics and medical science, human evolution and origins, climate change and the environment.
Saturday 18 February 2012
A vaccine against norovirus, a food poisoning virus that causes violent stomach flu, could be available within five years if it can be shown to be safe when taken as a nasal spray, scientists said.
Tests on laboratory animals have shown that a potential nasal vaccine against norovirus appears to generate the sort of immune response that should protect people against infection.
However, clinicial trials on hundreds of human volunteers over several years will be still be needed before the vaccine can be used by the general public, they said.
Although rarely fatal, norovirus can severely incapacitate people for up to three days. It is extremely contagious and spreads rapidly when people are confined together in situations such military camps or holiday cruise liners.
Professor Charles Arntzen of Arizona State University told the American Association for the Advancement of Science in Vancouver that scientists have developed a potential vaccine against the norovirus based on synthetic proteins found on the outer coating of the virus.
Researchers have genetically engineered tobacco plant to produce the viral coat proteins in their leaves. These proteins form empty viral “shells” that act as vaccine “antigens” that stimulate the immune response, Professor Arntzen said.
“We have created a vaccine that will be administered in a little device that puts a puff of powder up the nose. If you shoot it up one nostril it fills the nasal cavity on both sides. Our current formulation is showing wonderful immune response in animal tests,” Professor Arntzen said.
“The technical issues are probably solved, now it’s a regulatory issue. The US Food and Drug Administration has to go through every stage of development. If everything went well, we could have a vaccine in four or five years,” he said.
Norovirus in contaminated food attacks the body through the wall of the digestive gut but stimulating the immune defences of the body through the nose seems to be better than using an oral vaccine, Professor Arntzen said.
“It turns out that nasal immunisation works better than oral immunisation and it’s probably because the vaccine is degraded as it goes through the stomach and before it gets to the gut,” he said.
Further tests are needed to see if the vaccine can give some level of protection to at least 80 per cent of people who are vaccinated. This would provide the required “herd immunity” that could protect for instance people travelling on cruise ships.
“In situations like a cruise ship norovirus can spread like wildfire from one person to another. All that they have to do is for an infected person to leave as few as 10 viruses on a doorknob,” Professor Arntzen said.
“It’s a tough little virus. Once it gets into the environment it’s hard to get rid of and it causes this very rapid outbreak of disease. People recover usually after 72 hours but you can continue to shed virus for up to four weeks,” he explained.
Simon Calder looks at communities fighting back against the poachers
Arsenal 1 Everton 1: Substitute equalises with six minutes to go
booksGeese, gorillas, grandads... and growing up
Life & Style blogs
- 1 Turning up the voice of America
- 2 The poorest pay the price for austerity: Workers face biggest fall in living standards since Victorian era
- 3 The man who made Femen: New film outs Victor Svyatski as the mastermind behind the protest group and its breast-baring stunts
- 4 Mass murder in the Middle East is funded by our friends the Saudis
- 5 Japan cracks down on leaks after scandal of Fukushima nuclear power plant
- < Previous
- Next >
£80000 - £100000 per annum + Benefits + Bonus: Harrington Starr: Senior C++ De...
£25000 - £50000 per annum + Benefits + Bonus: Harrington Starr: C++ Server Dev...
£300 - £350 per day: Harrington Starr: Leading Electronic Trading Software Ven...
£23999 - £32001 per annum + Benefits: Pro-Recruitment Group: An independent ac...